Colagenose pulmão dominante em pacientes com doença pulmonar intersticial: prevalência, estabilidade funcional e manifestações extratorácicas comuns

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2015
Editora
SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JORNAL BRASILEIRO DE PNEUMOLOGIA, v.41, n.2, p.151-160, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To describe the characteristics of a cohort of patients with lung-dominant connective tissue disease (LD-CTD). Methods: This was a retrospective study of patients with interstitial lung disease (ILD), positive antinuclear antibody (ANA) results (>= 1/320), with or without specific autoantibodies, and at least one clinical feature suggestive of connective tissue disease (CO). Results: Of the 1,998 patients screened, 52 initially met the criteria for a diagnosis of LD-CTD: 37% were male; the mean age at diagnosis was 56 years; and the median follow-up period was 48 months. During follow-up, 8 patients met the criteria for a definitive diagnosis of a CTD. The remaining 44 patients comprised the LD-CTD group, in which the most prevalent extrathoracic features were arthralgia, gastroesophageal reflux disease, and Raynaud's phenomenon. The most prevalent autoantibodies in this group were ANA (89%) and anti-SSA (anti-Ro, 27%). The mean baseline and final FVC was 69.5% and 74.0% of the predicted values, respectively (p > 0.05). Nonspecific interstitial pneumonia and usual interstitial pneumonia patterns were found in 45% and 9% of HRCT scans, respectively; 36% of the scans were unclassifiable. A similar prevalence was noted in histological samples. Diffuse esophageal dilatation was identified in 52% of HRCT scans. Nailfold capillaroscopy was performed in 22 patients; 17 showed a scleroderma pattern. Conclusions: In our LD-CTD group, there was predominance of females and the patients showed mild spirometric abnormalities at diagnosis, with differing underlying ILD patterns that were mostly unclassifiable on HRCT and by histology. We found functional stability on follow-up. Esophageal dilatation on HRCT and scleroderma pattern on nailfold capillaroscopy were frequent findings and might come to serve as diagnostic criteria.
Palavras-chave
Idiopathic interstitial pneumonias, Autoantibodies, Connective tissue diseases, Autoimmunity
Referências
  1. Alhamad EH, 2012, RESP MED, V106, P1575, DOI 10.1016/j.rmed.2012.07.009
  2. American Thoracic Society, European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277
  3. Baldi BG, 2012, J BRAS PNEUMOL, V38, P282, DOI 10.1590/S1806-37132012000300002
  4. Corte TJ, 2012, EUR RESPIR J, V39, P661, DOI 10.1183/09031936.00174910
  5. De Angelis R, 2009, ARTHRIT RHEUM-ARTHR, V61, P405, DOI 10.1002/art.24274
  6. Fagundes MN, 2009, RESP MED, V103, P854, DOI 10.1016/j.rmed.2008.12.018
  7. Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194
  8. Fischer A, 2006, J RHEUMATOL, V33, P1600
  9. Fischer A, 2015, ARTHRIT CARE RES, V67, P4, DOI 10.1002/acr.22394
  10. Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC
  11. Kairalla RA., 2005, J BRAS PNEUMOL, V31, P1
  12. KATZENSTEIN ALA, 1994, AM J SURG PATHOL, V18, P136, DOI 10.1097/00000478-199402000-00003
  13. Kinder BW, 2010, LUNG, V188, P143, DOI 10.1007/s00408-009-9226-7
  14. Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC
  15. Lee JS, 2013, RESP MED, V107, P249, DOI 10.1016/j.rmed.2012.10.018
  16. Mittoo S, 2009, RESP MED, V103, P1152, DOI 10.1016/j.rmed.2009.02.009
  17. Momma Y, 1995, RESPIRATION, V62, P248
  18. Mosca M, 1998, LUPUS, V7, P95, DOI 10.1191/096120398678919787
  19. Oliveira CC, 2011, J BRAS PNEUMOL, V37, P168, DOI 10.1590/S1806-37132011000200006
  20. Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC
  21. Pereira Carlos Alberto de Castro, 2007, J Bras Pneumol, V33, P397, DOI 10.1590/S1806-37132007000400008
  22. Pereira DAS, 2013, J BRAS PNEUMOL, V39, P728, DOI 10.1590/S1806-37132013000600012
  23. Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP
  24. Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912
  25. Silva CIS, 2010, J BRAS PNEUMOL, V36, P99, DOI 10.1590/S1806-37132010000100016
  26. Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST
  27. Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC
  28. van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI 10.1136/annrheumdis-2013-204424
  29. Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662